======= PRPF18 ======= == Gene Information == * **Official Symbol**: PRPF18 * **Official Name**: pre-mRNA processing factor 18 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8559|8559]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99633|Q99633]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRPF18&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRPF18|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604993|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Participates in the second step of pre-mRNA splicing. {ECO:0000269|PubMed:9000057}. |PRP4| |Prp18| |U2-type post-spliceosomal complex| |nuclear mRNA surveillance of spliceosomal pre-mRNA splicing| |generation of catalytic spliceosome for second transesterification step| |nuclear retention of unspliced pre-mRNA at the site of transcription| |second spliceosomal transesterification activity| |nuclear retention of pre-mRNA at the site of transcription| |spliceosomal conformational changes to generate catalytic conformation| |intracellular mRNA localization| |nuclear RNA surveillance| |nuclear mRNA surveillance| |RNA surveillance| |U5 snRNP| |U4/U6 x U5 tri-snRNP complex| |spliceosomal complex| |nuclear-transcribed mRNA catabolic process| |mRNA catabolic process| |RNA localization| |ribonucleoprotein complex assembly| |ribonucleoprotein complex subunit organization| |RNA catabolic process| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions| |nucleobase-containing compound catabolic process| |RNA splicing| |nuclear speck| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |ribonucleoprotein complex biogenesis| |mRNA processing| |organic cyclic compound catabolic process| |mRNA metabolic process| |cellular protein-containing complex assembly| |RNA processing| |cellular macromolecule catabolic process| |macromolecule catabolic process| |protein-containing complex assembly| |cellular macromolecule localization| |RNA metabolic process| |negative regulation of gene expression| |organic substance catabolic process| |cellular catabolic process| |protein-containing complex subunit organization| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|-2.3| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-2.27| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|-1.96| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-1.8| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-1.76| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-1.74| |[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|-1.71| |[[:results:exp142|OICR-9429 10μM R03 exp142]]|1.7| |[[:results:exp116|AICAR 240μM R03 exp116]]|1.72| |[[:results:exp114|A-196 10μM R03 exp114]]|1.73| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|1.76| |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|1.77| |[[:results:exp516|Pyrazinamide 100μM R08 exp516]]|1.77| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|1.8| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|2.04| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|2.22| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|2.66| |[[:results:exp135|MS023 7μM R03 exp135]]|2.69| |[[:results:exp121|Golgicide-A 2μM R03 exp121]]|2.73| |[[:results:exp150|SGC0649 7μM R03 exp150]]|3.06| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 8/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|2/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|2/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1569 * **Expression level (log2 read counts)**: 4.48 {{:chemogenomics:nalm6 dist.png?nolink |}}